Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
01/16/2008 | EP1877099A2 Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting |
01/16/2008 | EP1877098A2 Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase |
01/16/2008 | EP1877097A2 Aminoacid conjugates of beta-lapachone for tumor targeting |
01/16/2008 | EP1877096A1 Non-lithotripsic kidney-stone therapy |
01/16/2008 | EP1877095A1 The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
01/16/2008 | EP1877094A1 Edible film for transmucosal delivery of nutritional supplements |
01/16/2008 | EP1877074A2 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells |
01/16/2008 | EP1877071A1 Method of improving immune function in mammals using 3-hpa producing lactobacillus strains in combination with medium chain triglyceride oil |
01/16/2008 | EP1877066A1 Use of azithromycin for the production of a medicament for treatment of ocular infections |
01/16/2008 | EP1877038A2 Cell-surface decoration with active agents |
01/16/2008 | EP1789019B1 Powders containing novel oligosaccharide mixtures and methods for producing the same |
01/16/2008 | EP1673063B1 Transdermal pharmaceutical composition |
01/16/2008 | EP1613644A4 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof |
01/16/2008 | EP1542904B1 Process for producing metered dose inhaler formulations |
01/16/2008 | EP1435929B1 Composition comprising cysteamine for improving lactation in dairy animals |
01/16/2008 | EP1326894B1 Novel tumor-associated marker |
01/16/2008 | EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
01/16/2008 | EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
01/16/2008 | EP0738141B1 Sucrose ester and n-docosanol formulations |
01/16/2008 | CN201006018Y Montmorillonite colon positioning releasing tablet |
01/16/2008 | CN201006014Y Montmorillonite colon positioning releasing capsule |
01/16/2008 | CN101107510A Method of measuring coating amount and method of estimating elution behavior |
01/16/2008 | CN101107270A Method of cross-linking hyaluronic acid with divinylsulfone |
01/16/2008 | CN101107267A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
01/16/2008 | CN101107015A Injection for mastitis |
01/16/2008 | CN101107014A Stabilisation of glucocorticoid esters with acids |
01/16/2008 | CN101107013A Bioactive compositions |
01/16/2008 | CN101107012A Methods for improving liver clearance of xenobiotic substances in an animal |
01/16/2008 | CN101106979A Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion |
01/16/2008 | CN101106977A Direct compression formulation and process |
01/16/2008 | CN101106969A O/W emulsion composition |
01/16/2008 | CN101104651A Preparation for modified chitosan metal complexes micro-sphere used for carrying medicament and preparation for the modified chitosan |
01/16/2008 | CN101104078A Polypeptide and protein medicine polyethylene coupling compound |
01/16/2008 | CN101104077A Recombinant human interleukin-2 and polyethylene coupling compound |
01/16/2008 | CN101104076A Compound fructose aseptic powder for injection and its clinical application |
01/16/2008 | CN101104043A Traditional Chinese medicine dispersion tablet for treating coronary heart disease and angina pectoris and preparing process thereof |
01/16/2008 | CN101104027A Cough-relieving traditional Chinese medicine micropill preparation and preparation method thereof |
01/16/2008 | CN101104015A Olive soft capsule raw material formulation and its preparation technology |
01/16/2008 | CN101103990A Composition containing sulfonylureas sugar-reducing drug and statins lipid-lowering drug |
01/16/2008 | CN101103984A Pharmaceutical compositions |
01/16/2008 | CN101103982A Palonosetron hydrochloride intravenous injection medicinal composition and preparation method thereof |
01/16/2008 | CN101103981A Medicinal composition containing tacrolimus |
01/16/2008 | CN101103980A Fexofenadine medicinal composition |
01/16/2008 | CN101103979A Azelnidipine medicinal composition and its preparing method |
01/16/2008 | CN101103978A Berberine resin composition and its preparation method and medicinal composition containing the same |
01/16/2008 | CN101103976A Oral medicinal composition containing anastrozole and preparation technology thereof |
01/16/2008 | CN101103975A Phenytoin sodium powder injection and preparation method thereof |
01/16/2008 | CN101103972A Oxaliplatinum liposome glucose preparation and its preparation method and application |
01/16/2008 | CN101103968A Ambroxol oral liquid with good taste |
01/16/2008 | CN101103967A Medicine composition containing bevantolol hydrochloride |
01/16/2008 | CN101103965A Stable solid preparation containing amorphous cefditoren pivoxil and preparation method thereof |
01/16/2008 | CN101103964A Sustained-release preparation containing felodipine and preparation method thereof |
01/16/2008 | CN101103963A Levalbuterol hydrochloride orally disintegrating tablet and preparation method thereof |
01/16/2008 | CN101103960A Dry mixed suspension containing racecadotril and preparation method thereof |
01/16/2008 | CN100362019C Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol |
01/16/2008 | CN100361985C Paclitaxol predrug of biodegradable polymer and its synthesis method |
01/16/2008 | CN100361709C Saccharide combination possessing protective function for life active compound |
01/16/2008 | CN100361664C Pharmaceutical formulations |
01/16/2008 | CN100361661C Stable eye lotion containing latanoprost as active ingredient |
01/16/2008 | CN100361655C (-)-epigallocatechin gallate-calcium complex solid dispersion and its prepn and application |
01/16/2008 | CN100361652C Gel type dexketoprofen plaster and method for preparing the same |
01/16/2008 | CN100361651C Intravenous nanoparticles for targenting drug delivery and sustained drug release |
01/15/2008 | US7319139 TAG-72 specific CH2 domain deleted antibodies |
01/15/2008 | US7319117 Mixture containing surfactant and polymer |
01/15/2008 | US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition |
01/15/2008 | US7319033 Transcritpional control; prostate glands; anticancer agents |
01/15/2008 | US7319004 Materials and methods relating to polyions and substance delivery |
01/15/2008 | US7318937 Liquid coating compositions |
01/15/2008 | US7318936 Minimization of drug oxidation in drug irradiated excipients formulations |
01/15/2008 | US7318931 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; and a metal, e.g., zinc; stabilized against denaturing when in contact with an organic solvent. |
01/15/2008 | US7318924 Antibodies against cancer |
01/15/2008 | US7318918 Interferon-alpha polypeptides and conjugates |
01/15/2008 | US7318840 Intervertebral disc treatment devices and methods |
01/15/2008 | CA2432225C Sustained release drug delivery devices with prefabricated permeable plugs |
01/15/2008 | CA2400567C Tamper-resistant oral opioid agonist formulations |
01/15/2008 | CA2339166C Dextran-maleic acid monoesters and hydrogels based thereon |
01/15/2008 | CA2332559C High molecular weight medicine-containing preparation in powder form for administration through mucosa |
01/15/2008 | CA2312839C Compositions for nasal administration |
01/15/2008 | CA2307776C Capsular preparation containing unsaturated fatty acid or derivative thereof and process for producing the same |
01/15/2008 | CA2279522C Biocompatible compounds for pharmaceutical drug delivery systems |
01/15/2008 | CA2251966C Transdermally administered dextromethorphan as antitussive agent |
01/15/2008 | CA2251087C Injection formulations of avermectins and milbemycins based on castor oil |
01/15/2008 | CA2250880C Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
01/15/2008 | CA2244389C Cilansetron pharmaceutical preparation stabilized against racemization |
01/15/2008 | CA2221496C Production scale method of forming microparticles |
01/15/2008 | CA2169191C Neural regeneration using human bone morphogenetic proteins |
01/15/2008 | CA2152563C Non-reducing saccharide and its production and use |
01/15/2008 | CA2132740C Pharmaceutical composition containing cyclosporin derivative |
01/10/2008 | WO2008005818A1 Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose |
01/10/2008 | WO2008005318A2 Chewy products and methods for making the same |
01/10/2008 | WO2008005240A2 Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof |
01/10/2008 | WO2008005039A1 Solid compositions comprising tadalafil and at least one carrier |
01/10/2008 | WO2008004978A1 Micelles for drug delivery |
01/10/2008 | WO2008004542A1 Method of separating vesicle, process for producing medicinal preparation, and method of evaluation |
01/10/2008 | WO2008004532A1 Substance-containing carbon nanohorn composite having polyamine plug and process for producing the same |
01/10/2008 | WO2008003706A1 Two step miniemulsion process |
01/10/2008 | WO2008003414A1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid |
01/10/2008 | WO2008003327A2 Immunotoxins for the treatment of diseases related to cmv infection |
01/10/2008 | WO2007125501A3 Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness |
01/10/2008 | WO2007044892A3 Upar-binding molecule-drug conjugates and uses thereof |